HIV Breakthrough Drug Faces Rollout Hurdles in Uganda
#HIVPrevention #GlobalHealthLenacapavir, a twice-yearly HIV prevention injection, shows unprecedented efficacy in Uganda trials. However, rollout faces criticism over limited access, high costs, and funding cuts, leaving many communities vulnerable despite the drug's promise. read more
Cambodia First in Asia to Hit HIV Treatment Target
#HIVPrevention #GlobalHealthCambodia became the first Asian nation to reach UNAIDS' 95-95-95 HIV targets, with 95% knowing status, on treatment, and virally suppressed. Success came from political will, community-led outreach, and stigma reduction, despite challenges across wealthier Asian countries. read more
Africa to Produce New HIV Prevention Drugs Locally
#GlobalHealth #HIVPreventionKenya, Uganda, and South Africa will receive Unitaid support to manufacture next-generation HIV prevention drugs like alimatravir, reducing reliance on imports. This aims to build resilient supply chains amid US aid cuts that closed clinics and disrupted access. read more
South Africa Launches HIV Prevention Shot Amid Funding Crisis
#HIVPrevention #GlobalHealthSouth Africa launched Lenacapavir, a biannual HIV prevention injection, hailed as a game-changer. However, U.S. aid cuts and high costs limit access. Generic versions expected by 2027 at $40 yearly could drastically cut infections if widely adopted. read more
Lenacapavir: Twice-Yearly Shot Could Transform HIV Fight
#HIVPrevention #GlobalHealthA long-acting HIV prevention injection offers hope for adolescent girls and young women in sub-Saharan Africa, removing daily pill burdens. Scaling up access through local production and affordable pricing could transform epidemic control and empower a generation. read more
Twice-Yearly HIV Shot Offers New Hope to Africa
#Lenacapavir #HIVPreventionA groundbreaking twice-yearly HIV prevention injection, lenacapavir, is rolling out in Eswatini. It offers near-complete protection, raising hopes to end the AIDS pandemic despite US aid cuts threatening broader access and global effectiveness. read more
HIV Funding Cuts Risk 10% Surge in U.S. Infections
#HIVPrevention #PublicHealthFundingProposed CDC funding cuts could increase U.S. HIV infections by 10% over five years, researchers warn. Over 1.2 million Americans live with HIV. Cuts threaten prevention programs, risking more transmissions and deaths. read more
HIV Prevention Shot Fails Kenyas Poorest
#HealthEquity #HIVPreventionKenya's rollout of the groundbreaking HIV prevention drug lenacapavir is failing to reach high-risk areas like Kibera. Despite its potential, high transport costs and clinic exclusions leave the most vulnerable without access, highlighting an equity gap in healthcare delivery. read more
UK Aid Cuts Imperil HIV Prevention Breakthrough
#HIVPrevention #GlobalHealthJusticeUK aid cuts threaten the rollout of Lenacapavir, a groundbreaking HIV prevention drug. This jeopardizes progress in sub-Saharan Africa, where women and girls face disproportionate risk. Political choices now determine if this medical breakthrough reaches those who need it most. read more
New HIV Shot Offers Hope Amid Funding Crisis
#HIVPrevention #GlobalHealthA groundbreaking twice-yearly HIV prevention injection, lenacapavir, is rolling out in Eswatini and eight other high-risk nations. Hailed as a potential pandemic-ender, its limited global scale and funding cuts threaten its lifesaving impact. read more
Trump Administration Considers Deep Cuts to HIV Prevention Program
#HIVprevention #TrumpadministrationThe Trump administration considers significant cuts to the CDC's HIV prevention program, sparking concerns from advocacy groups. Funding reductions could reverse progress in combating the HIV epidemic, jeopardizing lives and hindering the administration's goal to end the epidemic by 2030. read more